Increased microRNA-630 expression in gastric cancer is associated with poor overall survival

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Chu, Dake ^a,b   Zhao, Zhengwei ^c   Li, Yunming ^d   Li, Jipeng ^a   Zheng, Jianyong ^a   Wang, Weizhong ^a   Zhao, Qingchuan ^a   Ji, Gang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d CHENGDU MILITARY GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 630; UNCLASSIFIED DRUG; MIRN630 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSTIC VALUE; STOMACH CANCER; TUMOR INVASION; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL;

FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84898000670     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090526     Document Type: Article

References (34)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. DeSantis C, Naishadham D, Jemal A (2013) Cancer statistics for African Americans, 2013. CA Cancer J Clin 63: 151-166.
3. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63: 11-30.
4. Bray F, Sankila R, Ferlay J, Parkin DM (2002) Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 38: 99-166. (Pubitemid 34031832)
5. Dassen AE, Lemmens VE, van de Poll-Franse LV, Creemers GJ, Brenninkmeijer SJ, et al. (2010) Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands. Eur J Cancer 46: 1101-1110.
6. Lavy R, Kapiev A, Poluksht N, Halevy A, Keinan-Boker L (2013) Incidence trends and mortality rates of gastric cancer in Israel. Gastric Cancer 16: 121-125.
7. Jing JJ, Liu HY, Hao JK, Wang LN, Wang YP, et al. (2012) Gastric cancer incidence and mortality in Zhuanghe, China, between 2005 and 2010. World J Gastroenterol 18: 1262-1269.
8. Yang L (2006) Incidence and mortality of gastric cancer in China. World J Gastroenterol 12: 17-20.
9. Lin Y, Ueda J, Kikuchi S, Totsuka Y, Wei WQ, et al. (2011) Comparative epidemiology of gastric cancer between Japan and China. World J Gastroenterol 17: 4421-4428.
10. Inoue M, Tsugane S (2005) Epidemiology of gastric cancer in Japan. Postgrad Med J 81: 419-424. (Pubitemid 41002579)
11. Krol J, Krzyzosiak WJ (2006) Structure analysis of microRNA precursors. Methods Mol Biol 342: 19-32.
12. Iorio MV, Croce CM (2012) MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 4: 143-159.
13. Shah AA, Meese E, Blin N (2010) Profiling of regulatory microRNA transcriptomes in various biological processes: a review. J Appl Genet 51: 501-507.
14. Chen F, Hu SJ (2012) Effect of microRNA-34a in cell cycle, differentiation, and apoptosis: a review. J Biochem Mol Toxicol 26: 79-86.
15. Yanokura M, Banno K, Kobayashi Y, Kisu I, Ueki A, et al. (2010) MicroRNA and endometrial cancer: Roles of small RNAs in human tumors and clinical applications (Review). Oncol Lett 1: 935-940.
16. Srivastava K, Srivastava A (2012) Comprehensive review of genetic association studies and meta-analyses on miRNA polymorphisms and cancer risk. PLoS One 7: e50966.
17. Piva R, Spandidos DA, Gambari R (2013) From microRNA functions to microRNA therapeutics: Novel targets and novel drugs in breast cancer research and treatment (Review). Int J Oncol 43: 985-994.
18. Catto JW, Alcaraz A, Bjartell AS, De Vere White R, Evans CP, et al. (2011) MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur Urol 59: 671-681.
19. Mazeh H, Mizrahi I, Ilyayev N, Halle D, Brucher B, et al. (2013) The Diagnostic and Prognostic Role of microRNA in Colorectal Cancer - a Comprehensive review. J Cancer 4: 281-295.
20. Chan SH, Wu CW, Li AF, Chi CW, Lin WC (2008) miR-21 microRNA expression in human gastric carcinomas and its clinical association. Anticancer Res 28: 907-911. (Pubitemid 351578936)
21. Zhao Y, Li C, Wang M, Su L, Qu Y, et al. (2013) Decrease of miR-202-3p Expression, a Novel Tumor Suppressor, in Gastric Cancer. PLoS One 8: e69756.
22. Guo LH, Li H, Wang F, Yu J, He JS (2013) The Tumor Suppressor Roles of miR-433 and miR-127 in Gastric Cancer. Int J Mol Sci 14: 14171-14184.
23. Wang SH, Li X, Zhou LS, Cao ZW, Shi C, et al. (2013) microRNA-148a suppresses human gastric cancer cell metastasis by reversing epithelial-to-mesenchymal transition. Tumour Biol.
24. Wang W, Li F, Zhang Y, Tu Y, Yang Q, et al. (2013) Reduced expression of miR-22 in gastric cancer is related to clinicopathologic characteristics or patient prognosis. Diagn Pathol 8: 102.
25. Liu X, Ru J, Zhang J, Zhu LH, Liu M, et al. (2013) miR-23a targets interferon regulatory factor 1 and modulates cellular proliferation and paclitaxel-induced apoptosis in gastric adenocarcinoma cells. PLoS One 8: e64707.
26. Esteller M (2011) Non-coding RNAs in human disease. Nat Rev Genet 12: 861-874.
27. He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5: 522-531. (Pubitemid 38868508)
28. Mendell JT (2005) MicroRNAs: critical regulators of development, cellular physiology and malignancy. Cell Cycle 4: 1179-1184.
29. Kasinski AL, Slack FJ (2011) Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 11: 849-864.
30. Patnaik SK, Kannisto E, Knudsen S, Yendamuri S (2010) Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection. Cancer Res 70: 36-45.
31. Galluzzi L, Morselli E, Vitale I, Kepp O, Senovilla L, et al. (2010) miR-181a and miR-630 regulate cisplatin-induced cancer cell death. Cancer Res 70: 1793-1803.
32. Huang Y, Chuang A, Hao H, Talbot C, Sen T, et al. (2011) Phospho-DeltaNp63alpha is a key regulator of the cisplatin-induced microRNAome in cancer cells. Cell Death Differ 18: 1220-1230.
33. Huang Y, Guerrero-Preston R, Ratovitski EA (2012) Phospho-DeltaNp63alpha- dependent regulation of autophagic signaling through transcription and micro-RNA modulation. Cell Cycle 11: 1247-1259.
34. Farhana L, Dawson MI, Murshed F, Das JK, Rishi AK, et al. (2013) Upregulation of miR-150*and miR-630 induces apoptosis in pancreatic cancer cells by targeting IGF-1R. PLoS One 8: e61015.